Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as Cetirizine Hydrochloride
Cetirizine · 2 trials · 1 indication
| Arm | Type | Description |
|---|---|---|
| Cetirizine | EXPERIMENTAL | Cetirizine Hydrochloride Tablets 10 mg of Dr. Reddys Laboratories Limited |
| Zyrtec | ACTIVE_COMPARATOR | Zyrtec Tablets 10 mg of Pfizer Labs |
| Name | Type | Description |
|---|---|---|
| Cetirizine Hydrochloride | DRUG | Cetirizine Hydrochloride Tablets 10 mg |
Inclusion Criteria: 1. Healthy males between 18 and 45 years of age (both inclusive) living in and around Ahmedabad city of western part of India. 2. Having a Body Mass Index (BMI) between 18.5 and 24.9 {both inclusive), calculated as weight in kg/height in m2 3. Not having any significant diseases...
Cetirizine is a small molecule drug developed by Dr. Reddy's Laboratories Ltd, which trades under the ticker RDY. It is being studied in Phase 1 clinical trials. The specific medical conditions it is intended to treat have not been disclosed.
Cetirizine targets HRH1, the histamine H1 receptor. It acts as an antagonist at this receptor. By blocking HRH1, cetirizine interferes with histamine signaling, which is the mechanism underlying its pharmacological activity.
Cetirizine is developed by Dr. Reddy's Laboratories Ltd, a pharmaceutical company whose shares trade under the ticker symbol RDY. The company is responsible for the clinical development of this drug candidate.
Cetirizine is in Phase 1 clinical development. It is an investigational drug and has not been approved by the FDA. The Phase 1 program consists of two completed trials, with no active trials currently listed.
Cetirizine has been evaluated in two completed Phase 1 trials. NCT01064115 is a bioequivalence study of cetirizine hydrochloride 10 mg tablets under fed conditions, and NCT01064102 is a bioequivalence study of the same tablets under fasting conditions. Both enrolled 30 healthy male volunteers.
Yes, Cetirizine Hydrochloride is another name for Cetirizine. The two names refer to the same drug substance. The clinical trials registered for this asset use the name Cetirizine Hydrochloride.